Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (15-PGDH, HPGD)

Aspirin use reduces the risk of colorectal neoplasia, at least in part, through inhibition of prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase 2)-related pathways. Hydroxyprostaglandin dehydrogenase 15-(NAD) (15-PGDH, HPGD) is downregulated in colorectal cancers and functions as a metabo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Fink, Stephen P., Yamauchi, Mai, Nishihara, Reiko, Jung, Seungyoun, Kuchiba, Aya, Wu, Kana, Cho, Eunyoung, Giovannucci, Edward, Fuchs, Charles S., Ogino, Shuji, Markowitz, Sanford D., Chan, Andrew T.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030641/
https://ncbi.nlm.nih.gov/pubmed/24760190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3008481
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items